Thomas Kuhn


Thomas studied pharmacy in Saarbrücken until 2017 and is working on his PhD project in the Biogenic Nanotherapeutics group since 2018. His research interests include membrane vesicles derived from probiotic bacteria and eukaryotic cells in the context of novel anti-inflammatory therapeutic options. His work is funded by the Studienstiftung des Deutschen Volkes.


Stimulation of Probiotic Bacteria Induces Release of Membrane Vesicles with Augmented Anti-inflammatory Activity

Müller L, Kuhn T, Koch M, Fuhrmann G (2021)

ACS Appl. Bio Mater.DOI: 10.1021/acsabm.0c01136


Myxobacteria-Derived Outer Membrane Vesicles: Potential Applicability Against Intracellular Infections

Goes A, Lapuhs P, Kuhn T, Schulz E, Richter R, Panter F, Dahlem C, Koch M, Garcia R, Kiemer A, Müller R, Fuhrmann G (2020)

Cells 9 (1)DOI: 10.3390/cells9010194

Probiomimetics-Novel Lactobacillus-Mimicking Microparticles Show Anti-Inflammatory and Barrier-Protecting Effects in Gastrointestinal Models

Kuhn T, Koch M, Fuhrmann G (2020)

Small (Weinheim an der Bergstrasse, Germany) 16 (40)DOI: 10.1002/smll.202003158